StonvexLoading…
StonvexStonvexStonvexCore line items from PCOR's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $359.28M | $1.32B | $973.40M | $634.55M |
Operating Income | $-15.67M | $-124.34M | $-81.54M | $-66.51M |
Net Income | $-9.10M | $-100.78M | $-63.18M | $-54.08M |
EPS (Diluted) | $-0.06 | $-0.67 | $-0.42 | $-0.36 |
Total Assets | $2.11B | $2.24B | $2.06B | $2.00B |
Total Liabilities | $908.07M | $976.80M | $834.46M | $786.50M |
Cash & Equivalents | $386.04M | $480.68M | $350.50M | $324.26M |
Free Cash Flow OCF − CapEx | $73.83M | $282.17M | $172.93M | $89.85M |
Shares Outstanding | 150.75M | 151.71M | 150.46M | 150.19M |